Agnes S Klar1,2, Sinan Güven3, Jakub Zimoch1,2, Natalia A Zapiórkowska1,2, Thomas Biedermann1,2, Sophie Böttcher-Haberzeth1,2,4, Claudia Meuli-Simmen5, Ivan Martin3, Arnaud Scherberich3, Ernst Reichmann1,2, Martin Meuli6. 1. Tissue Biology Research Unit, Department of Surgery, University Children's Hospital Zurich, Zurich, Switzerland. 2. Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. 3. Department of Biomedicine, University Hospital of Basel, University of Basel, Basel, Switzerland. 4. Department of Surgery, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland. 5. Department of Plastic, Reconstructive, Esthetical and Hand Surgery, Kantonsspital Aarau, Aarau, Switzerland. 6. Department of Surgery, University Children's Hospital Zurich, Steinwiesstrasse 75, 8032, Zurich, Switzerland. Martin.Meuli@kispi.uzh.ch.
Abstract
PURPOSE: The need for clinically applicable skin substitutes continues to be a matter of fact. Hypothetically, a laboratory grown autologous skin analog with near normal architecture might be a suitable approach to yield both satisfactory functional and cosmetic long-term results. In this study, we explored the use of human endothelial cells derived from freshly isolated adipose stromal vascular fraction (SVF) in a three-dimensional (3D) co-culture model of vascularized bio-engineered skin substitute. METHODS: The SVF was isolated from human white adipose tissue samples and keratinocytes from human skin biopsies. The SVF, in particular endothelial cells, were characterized using flow cytometry and immuofluorescence analysis. Endothelial and mesenchymal progenitors from the SVF formed blood capillaries after seeding into a 3D collagen type I hydrogel in vitro. Subsequently, human keratinocytes were seeded on the top of those hydrogels to develop a vascularized dermo-epidermal skin substitute. RESULTS: Flow cytometric analysis of surface markers of the freshly isolated SVF showed the expression of endothelial markers (CD31, CD34, CD146), mesenchymal/stromal cell-associated markers (CD44, CD73, CD90, CD105), stem cell markers (CD49f, CD117, CD133), and additionally hematopoietic markers (CD14, CD15, CD45). Further analysis of white adipose-derived endothelial cells (watECs) revealed the co-expression of CD31, CD34, CD90, CD105, and partially CD146 on these cells. WatECs were separated from adipose-stromal cells (watASCs) using FACS sorting. WatASCs and watECs cultured separately in a 3D hydrogel for 3 weeks did not form any vascular structures. Only if co-cultured, both cell types aligned to develop a ramified vascular network in vitro with continuous endothelial lumen formation. Transplantation of those 3D-hydrogels onto immuno-incompetent rats resulted in a rapid connection of human capillaries with the host vessels and formation of functional, blood-perfused mosaic human-rat vessels within only 3-4 days. CONCLUSIONS: Adipose tissue represents an attractive cell source due to the ease of isolation and abundance of endothelial as well as mesenchymal cell lineages. Adipose-derived SVF cells exhibit the ability to form microvascular structures in vitro and support the accelerated blood perfusion in skin substitutes in vivo when transplanted.
PURPOSE: The need for clinically applicable skin substitutes continues to be a matter of fact. Hypothetically, a laboratory grown autologous skin analog with near normal architecture might be a suitable approach to yield both satisfactory functional and cosmetic long-term results. In this study, we explored the use of human endothelial cells derived from freshly isolated adipose stromal vascular fraction (SVF) in a three-dimensional (3D) co-culture model of vascularized bio-engineered skin substitute. METHODS: The SVF was isolated from human white adipose tissue samples and keratinocytes from human skin biopsies. The SVF, in particular endothelial cells, were characterized using flow cytometry and immuofluorescence analysis. Endothelial and mesenchymal progenitors from the SVF formed blood capillaries after seeding into a 3D collagen type I hydrogel in vitro. Subsequently, human keratinocytes were seeded on the top of those hydrogels to develop a vascularized dermo-epidermal skin substitute. RESULTS: Flow cytometric analysis of surface markers of the freshly isolated SVF showed the expression of endothelial markers (CD31, CD34, CD146), mesenchymal/stromal cell-associated markers (CD44, CD73, CD90, CD105), stem cell markers (CD49f, CD117, CD133), and additionally hematopoietic markers (CD14, CD15, CD45). Further analysis of white adipose-derived endothelial cells (watECs) revealed the co-expression of CD31, CD34, CD90, CD105, and partially CD146 on these cells. WatECs were separated from adipose-stromal cells (watASCs) using FACS sorting. WatASCs and watECs cultured separately in a 3D hydrogel for 3 weeks did not form any vascular structures. Only if co-cultured, both cell types aligned to develop a ramified vascular network in vitro with continuous endothelial lumen formation. Transplantation of those 3D-hydrogels onto immuno-incompetent rats resulted in a rapid connection of human capillaries with the host vessels and formation of functional, blood-perfused mosaic human-rat vessels within only 3-4 days. CONCLUSIONS: Adipose tissue represents an attractive cell source due to the ease of isolation and abundance of endothelial as well as mesenchymal cell lineages. Adipose-derived SVF cells exhibit the ability to form microvascular structures in vitro and support the accelerated blood perfusion in skin substitutes in vivo when transplanted.
Authors: Andrew C Boquest; Aboulghassem Shahdadfar; Katrine Frønsdal; Olafur Sigurjonsson; Siv H Tunheim; Philippe Collas; Jan E Brinchmann Journal: Mol Biol Cell Date: 2005-01-05 Impact factor: 4.138
Authors: Irene Montaño; Clemens Schiestl; Jörg Schneider; Luca Pontiggia; Joachim Luginbühl; Thomas Biedermann; Sophie Böttcher-Haberzeth; Erik Braziulis; Martin Meuli; Ernst Reichmann Journal: Tissue Eng Part A Date: 2010-01 Impact factor: 3.845
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: Thomas Biedermann; Sophie Böttcher-Haberzeth; Agnieszka S Klar; Luca Pontiggia; Clemens Schiestl; Claudia Meuli-Simmen; Ernst Reichmann; Martin Meuli Journal: Pediatr Surg Int Date: 2013-01 Impact factor: 1.827
Authors: Cristina Blanco-Elices; Jesús Chato-Astrain; Salvador Oyonarte; Fabiola Bermejo-Casares; Antonio España-López; Ricardo Fernández-Valadés; Maria Del Carmen Sánchez-Quevedo; Miguel Alaminos; Miguel Angel Martín-Piedra; Ingrid Garzón Journal: J Periodontal Res Date: 2021-09-12 Impact factor: 3.946
Authors: Mohammad Amir Amirkhani; Alireza Shoae-Hassani; Masoud Soleimani; Somayeh Hejazi; Leila Ghalichi; Mohammad Ali Nilforoushzadeh Journal: Bioimpacts Date: 2016-09-30
Authors: Hanneke N Monsuur; Ester M Weijers; Frank B Niessen; Amit Gefen; Pieter Koolwijk; Susan Gibbs; Lenie J van den Broek Journal: PLoS One Date: 2016-11-30 Impact factor: 3.240